Neurons

FDA Approves New Drug for Multiple Sclerosis

Multiple sclerosis (MS) is a neurological disease that affects over 2 million people worldwide. In patients who suffer from MS, an abnormal immune response causes damage to a fatty substance called myelin. Like the coating around an electrical wire, myelin insulates nerve cells and facilitates neural communication. Symptoms of MS include muscle weakness, fatigue, and impaired speech. On March 28th 2017, the FDA approved Ocrevus, an … Continue reading FDA Approves New Drug for Multiple Sclerosis

pills-1885550_1920

Make the FDA Great Again? Trump and the future of the drug approval process

Update: Since the writing of this article, Donald Trump has picked Scott Gottleib as FDA commissioner. -SITN editorial staff by Linda Honaker figures by Rebecca Clements Donald Trump will soon pick a new commissioner for the Federal Drug Administration (FDA). The choice will likely be someone who will try to make the administration’s drug approval requirements less rigorous in order to get drugs on the … Continue reading Make the FDA Great Again? Trump and the future of the drug approval process